scholarly journals Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)

2018 ◽  
Vol 183 (2) ◽  
pp. 235-241 ◽  
Author(s):  
Jürgen Krauter ◽  
Walter Fiedler ◽  
Richard F. Schlenk ◽  
Peter Paschka ◽  
Felicitas Thol ◽  
...  
Keyword(s):  
High Risk ◽  
Acute Myeloid Leukaemia ◽  
Phase I ◽  
Myeloid Leukaemia ◽  
Newly Diagnosed ◽  
Induction Failure ◽  
Acute Myeloid

scholarly journals Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS

2015 ◽  
Vol 172 (2) ◽  
pp. 238-245 ◽  
Author(s):  
Raya Mawad ◽  
Pamela S. Becker ◽  
Paul Hendrie ◽  
Bart Scott ◽  
Brent L. Wood ◽  
...  
Keyword(s):  
High Risk ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Phase Ii ◽  
Older Patients ◽  
Phase Ii Study ◽  
Newly Diagnosed ◽  
Acute Myeloid

Bone marrow mononuclear cell telomere length in acute myeloid leukaemia and high‐risk myelodysplastic syndrome

2019 ◽  
Vol 102 (3) ◽  
pp. 218-226
Author(s):  
Marie Warny ◽  
Jens Helby ◽  
Henrik Sengeløv ◽  
Børge G. Nordestgaard ◽  
Henrik Birgens ◽  
...  
Keyword(s):  
Bone Marrow ◽  
High Risk ◽  
Acute Myeloid Leukaemia ◽  
Myelodysplastic Syndrome ◽  
Myeloid Leukaemia ◽  
Telomere Length ◽  
Mononuclear Cell ◽  
Bone Marrow Mononuclear Cell ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document